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Amodular synthesis of enantioenriched polyfunctionalized cyclobutanes was developed that features an 8-
aminoquinolinamide directed C–H arylation reaction. The C–H arylation products were derivatized through
subsequent decarboxylative coupling processes. This synthetic strategy enabled a 9-step enantioselective
total synthesis of the antiproliferative meroterpenoid (+)-rumphellaone A.Introduction
The cyclobutane structural motif is present in a variety of
natural products and pharmaceutical molecules (Scheme 1).1,2n strategy to access (+)-rum-
aboratory of Chemistry and Chemical
logy, Pasadena, CA 91125, USA. E-mail:
tion (ESI) available. See DOI:
is work.
hemistry 2019Cyclobutanes are also versatile synthetic intermediates, as the
ring strain inherent to these structures engenders them with
unique reactivity that can be leveraged in a variety of trans-
formations to build complex frameworks.3 [2 + 2] cycloaddition
reactions represent the most extensively developed approach to
construct cyclobutanes, and recent advances have given rise to
elegant enantioselective reactions.4 An alternative strategy is to
prepare a versatile cyclobutane building block, and then use
C–H functionalization or cross-coupling chemistry to elaborate
the scaﬀold in a modular fashion.5 In this latter approach,
a single enantioenriched intermediate can quickly be converted
to a variety of more functionalized structures.
We recently reported a synthesis of the natural product
(+)-psiguadial B (1), which featured a tandem Wolﬀ-
rearrangement/asymmetric ketene addition to prepare enan-
tioenriched 8-aminoquinolinamide 4 (Scheme 1).6 Given the
short synthesis of 4 from commercial starting materials, we
became interested in further applications of this chiral building
block. Specically, we envisioned that directed C–H arylation
could enable diversication at the b-position,7 while hydrolysis
of the 8-aminoquinolinamide followed by decarboxylative
radical cross-coupling could enable diversication at the a-
position. A number of powerful methods have been developed
that leverage the decarboxylative formation of carbon-centered
radicals for C–C and C–X bond formation.8 It was anticipated
that the sequence of C–H arylation followed by decarboxylative
coupling could provide access to a collection of enantioenriched
polyfunctionalized cyclobutanes.Results and discussion
We began by investigating the scope of the directed C–H ary-
lation of 8-aminoquinolinamide 4, which was prepared in three
steps and 99% ee from commercially available 2,2-dimethylcy-
clopentan-1-one.6 Using our previously developed conditions
[Pd(OAc)2 (15 mol%), Ag2CO3 (1.0 equiv.), aryl iodide (2.0
equiv.), TBME, 90 C], a series of cis-arylated cyclobutanes wereChem. Sci., 2019, 10, 2315–2319 | 2315
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View Article Onlineprepared in good yields (Scheme 2).9 The reaction was
compatible with both electron-rich and electron-decient aryl
iodides and tolerated substitution at the ortho, meta, and para
positions. Heteroaryl iodides were also found to be competent
coupling partners, allowing for incorporation of pyridines,
pyrimidines, and indoles. Unfortunately, with 5-iodo-2-
phenylpyridine or 5-iodo-2-methoxypyrimidine, the reaction
proceeded in only modest yields (<40%). Aryl triates failed to
react under the optimized reaction conditions.
Having established the generality of the C–H arylation step,
we turned our attention to diversication at the carbon bearing
the 8-aminoquinolinamide through functional group intercon-
version or decarboxylative cross-coupling. To this end, hydro-
lysis of 9d proceeded with epimerization to the
thermodynamically favored trans diastereomer, delivering
trans-cyclobutanoic acid 10 (Scheme 3).10 Reduction of the acid
delivered alcohol 12, which could be oxidized under Stahl
conditions to aldehyde 13.11 Alternatively, 10 could be converted
to the corresponding acid chloride and engaged in a nickel-
catalyzed reductive cross-coupling with iodocyclohexane to
access ketone 14.12 In order to investigate decarboxylative
coupling processes, acid 10 was subjected to EDC-mediated
coupling with N-hydroxyphthalimide to provide NHP ester
11.13 Ni-catalyzed coupling of 11 with arylzinc chloride 15 gaveScheme 2 Scope of the C–H arylation of 4. Reactions were con-
ducted on 0.20 mmol scale in a sealed 2-dram vial using Pd(OAc)2
(15 mol%), Ag2CO2 (1.0 equiv.), 5a–p (2.0 equiv.), [4] ¼ 0.2 M in TBME.
TBME ¼ tert-butyl methyl ether.
Scheme 3 Selected derivatizations of 10. ABNO ¼ 9-azabicylo[3.3.1]
nonane N-oxyl. NMI ¼ N-methylimidazole. NHPI ¼ N-hydroxyph-
thalimide. EDC ¼ 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
DMAP ¼ 4-dimethylaminopyridine. TFA ¼ triﬂuoroacetic acid. dtbbpy
¼ di-tert-butylbipyridine. dme ¼ dimethoxyethane. 4,40-MeObpy ¼
4,40-dimethoxybipyridine. [Ir] ¼ Ir[dF(CF3)ppy]2(dtbbpy)PF6.
2316 | Chem. Sci., 2019, 10, 2315–2319trans-diarylcyclobutane 16 in good yield as a single diaster-
eomer.8d Similarly, NHP ester 11 underwent Ni-catalyzed
reductive alkenylation with styrenyl bromide 17 to furnish
cyclobutane 18 in 56% yield.8c,e Photoinduced decarboxylative
borylation of 11 proceeded smoothly to aﬀord boronic ester
20,8h and decarboxylative Minisci type arylation of 11 under
photoredox catalysis delivered quinoline 19.8i
To further demonstrate the utility of this cyclobutane
difunctionalization strategy, we designed and executed
a synthesis of the natural product (+)-rumphellaone A (8).14
(+)-Rumphellaone A (8) was isolated in 2010 from the gorgonian
coral Rumphella antipathies and possesses anti-proliferative
activity against human T-cell acute lymphoblastic leukemia
tumor cells.2d Retrosynthetically, we envisioned disconnectingThis journal is © The Royal Society of Chemistry 2019
Scheme 5 Synthesis of (+)-rumphellaone A (8).
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View Article Onlinethrough the C1–C2 bond to give 21 (Scheme 4); in the forward
sense, the ketone fragment would be incorporated through
a decarboxylative Giese addition with methyl vinyl ketone. The
butenolide of 21 could derive from oxidation of furan 22, which
could be prepared from 4 by a directed C–H arylation. As a proof
of concept, 8-aminoquinolinamide 4 was subjected to Pd-
catalyzed C–H functionalization with furanyl iodide 23 to give
cis-cyclobutane 24 in 90% yield.15 Hydrolysis and subsequent
decarboxylative Giese reaction with methyl vinyl ketone under
photoredox catalysis provided 25 in 50% yield over two steps.16
Having validated the feasibility of the two key cyclobutane
functionalization reactions, attention turned to the unmasking
of the butenolide functionality prior to the decarboxylative
Giese reaction. Treatment of 22 with sodium chlorite under
buﬀered conditions17 delivered 5-hydroxybutenolide 26
(Scheme 5). The remaining challenge was installation of the C8
methyl substituent with the required S-conguration. In prior
syntheses of 8, this stereogenic center was set under the guid-
ance of chiral catalyst control.14Given that the C8 diastereomers
were inseparable by column chromatography, high diaster-
eoselectivity for this methyl addition was important.
Aer exploring a range of conditions to eﬀect the methyla-
tion, we were pleased to discover that either C8 diastereomer (27
or 28) could be prepared using the appropriate methyltitanium
reagent. Thus, addition of 26 to a pre-formed 1 : 1 mixture of
(iPrO)3 TiCl and MeLi at 78 C, with warming to 23 C, deliv-
ered the undesired C8 diastereomer, 27, in 76% yield and 22 : 1
dr.18 Alternatively, addition of 26 to a78 C solution of Ti(Me)4
in dichloromethane,19 which was prepared in situ by combining
MeLi and TiCl4 in a 4 : 1 ratio, provided the desired diaste-
reomer 28 in 60% yield and 9 : 1 dr. We hypothesize that the
divergent diastereoselectivity for these two reactions resulted
from the diﬀerent methylating reagents, (iPrO)3TiMe or Ti(Me)4,Scheme 4 Retrosynthetic analysis of 8 and key proof-of-concept
study. TMS ¼ trimethylsilyl. MVK ¼ methyl vinylketone.
This journal is © The Royal Society of Chemistry 2019prepared in situ. One possible explanation is that 27 formed by
ligand exchange of the carboxylic acid of 26 with (iPrO)3TiMe
followed by intramolecular delivery of the methyl nucleophile,
while 28 resulted from addition of Ti(Me)4 without the assis-
tance of chelation.
To complete the synthesis, 28 was reduced under standard
hydrogenation conditions. Decarboxylative Giese addition of 28
to methyl vinyl ketone under photoredox catalysis provided
(+)-rumphellaone A (8) in good yield, completing the synthesis
in 9 steps from commercially available material. Epimeric acid
27 could be analogously elaborated to (+)-epi-C8-rumphellaone
A (29).Conclusions
Through a strategy for difunctionalization, we have demon-
strated that 8-aminoquinolinamide 4 can serve as a valuable
building block for the synthesis of enantioenriched cyclo-
butanes. We further illustrated this concept in a 9-step
synthesis of (+)-rumphellaone A (8). We anticipate that this
general strategy could enable the expedient synthesis of addi-
tional natural products and other bioactive molecules.Conﬂicts of interest
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